Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...

Cockapoos are the UK's most popular dog breed, but a leading vet has issued a warning over the beloved family pet, after ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

Around 31 million U.S. adults have taken a GLP-1 (half are still on it) and 12.5 million or more are doing it because they're obese or overweight. And while the medications offer some folks an ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with chronic migraines. Participants experienced nearly a 50% reduction in ...

China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Could something as simple as dairy colostrum help keep the weight off? A UW Dairy Innovation Hub researcher thinks so.

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

A brief research report evaluated obesity among U.S. children and adolescents from 2011 to August 2023 and compared changes ...